Tegaserod maleate
Tegaserod maleate (SDZ-HTF-919) is a selective 5-HT4 receptor agonist developed by Novartis. It was previously approved for IBS with constipation but was withdrawn due to cardiovascular risk concerns. This compound remains a valuable research tool for studying serotonergic pathways in gastrointestinal motility and related in vitro and in vivo models.
Product Specifications
CAS Number
189188-57-6
Product Name Alternative
5-HT, 5HTReceptor, 5-hydroxytryptamine Receptor, 5HT Receptor, 5-HT Receptor, bowel, inhibit, irritable, SDZ-HTF 919, SDZ-HTF919, SDZ-HTF-919, HTF 919, HTF919, HTF-919, IBS, Inhibitor, Gastrointestinal, Serotonin Receptor, Sert (Sodium-dependent), syndrome, Tegaserod, Tegaserod maleate, Tegaserod Maleate
Field of Research
Cell Biology, Neuroscience, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:125 mg/mL (299.43 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.79 mM)
Smiles
C (=C\C (O) =O) \C (O) =O.C (=NNC (NCCCCC) =N) C=1C=2C (NC1) =CC=C (OC) C2
Molecular Formula
C20H27N5O5
Molecular Weight
417.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
247374-ML750 100 µL
ID3 (Inhibitor of DNA Binding 3, Dominant Negative Helix-loop-Helix Protein, HEIR-1, bHLHb25) (MaxLight 750) discontinued
Sign In for Pricing
View Details CEC39492 25 mg
Methyl 4-bromo-1H-pyrrolo[2,3-b]pyridine-6-carboxylate
Sign In for Pricing
View Details